Sanofi (EPA:SAN)
France flag France · Delayed Price · Currency is EUR
71.01
-0.93 (-1.29%)
Oct 19, 2026, 5:39 PM CET

Sanofi Stock Forecast

Stock Price Forecast

According to 25 analysts polled by S&P Global, Sanofi stock has a consensus rating of "Buy" and an average price target of €93.35. The average 1-year stock price forecast is 31.46% higher than the current stock price, while the lowest is €75.00 (+5.62%) and the highest is €107.20 (+50.96%).

Price Target: €93.35 (+31.46%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price€75.00€93.35€95.00€107.20
Change+5.62%+31.46%+33.78%+50.96%

Analyst Ratings

The average analyst rating for Sanofi stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingMay '26Jun '26Jul '26Aug '26Sep '26Oct '26
Strong Buy101010101010
Buy212222
Hold121212121313
Sell000000
Strong Sell000000
Total242324242525

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
RBC Capital
RBC Capital
Hold
Maintains
€80.00 → €75.00
HoldMaintains€80.00 → €75.00+5.62%Oct 16, 2026
UBS
UBS
Hold
Maintains
€78.00
HoldMaintains€78.00+9.84%Oct 15, 2026
Bank of America Securities
Bank of America Securities
Hold
Reiterates
€92.00
HoldReiterates€92.00+29.56%Oct 8, 2026
Jefferies
Jefferies
Buy
Maintains
€100.00
BuyMaintains€100.00+40.83%Oct 7, 2026
J.P. Morgan
J.P. Morgan
Hold
Maintains
€95.00
HoldMaintains€95.00+33.78%Oct 7, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
47.40B
from 46.72B
Increased by 1.46%
Revenue Next Year
50.49B
from 47.40B
Increased by 6.51%
EPS This Year
8.56
from 7.83
Increased by 9.31%
EPS Next Year
9.02
from 8.56
Increased by 5.43%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
39.18B40.30B41.11B44.29B46.72B47.40B
Revenue Growth
4.83%2.88%2.00%7.73%5.49%1.46%
Gross Profit
26.92B28.44B28.49B31.09B33.79B36.00B
Gross Margin
68.73%70.55%69.30%70.21%72.34%75.96%
Operating Income
8.57B10.38B8.12B8.87B9.65B13.12B
Net Income
6.22B8.37B5.40B5.56B7.81B7.46B
EPS
----7.838.56
EPS Growth
----9.97%9.31%
Forward PE
12.5410.6011.1311.5010.038.30
Dividend / Share
3.333.563.763.924.124.26
Dividend Growth
4.06%6.91%5.62%4.26%5.10%3.30%
Free Cash Flow
----8.09B8.23B
No. Analysts
-----14
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is EUR.

Revenue Forecast

Revenue202620272028
High48.4B
Avg47.4B
Low43.3B

Revenue Growth

Revenue Growth202620272028
High
3.7%
Avg
1.5%
Low
-7.2%

EPS Forecast

EPS202620272028
High8.93
Avg8.56
Low7.66

EPS Growth

EPS Growth202620272028
High
14.0%
Avg
9.3%
Low
-2.2%